Natural Product: NPC488884

Natural Product IDNPC488884
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
JTVHSBUECOEPGS-UAFRVZNXSA-N
IUPAC Name n.a.
Synonyms
Synthetic Gene Cluster n.a.
ChEMBL Identifier n.a.
PubChem CID n.a.
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey JTVHSBUECOEPGS-UAFRVZNXSA-N
Standard InCHI InChI=1S/C122H82O78/c123-39-1-24(2-40(124)68(39)142)104(165)189-97-95-60(22-180-110(171)30-13-47(131)73(147)82(156)62(30)64-32(112(173)187-95)15-49(133)75(149)84(64)158)184-119-100(97)193-116(177)36-19-53(137)79(153)88(162)91(36)182-58-11-28(7-45(129)71(58)145)108(169)197-120-101(98(190-105(166)25-3-41(125)69(143)42(126)4-25)96-61(185-120)23-181-111(172)31-14-48(132)74(148)83(157)63(31)65-33(113(174)188-96)16-50(134)76(150)85(65)159)194-117(178)37-20-54(138)80(154)89(163)92(37)183-59-12-29(8-46(130)72(59)146)109(170)198-121-102(195-118(179)38-21-55(139)81(155)90(164)93(38)186-94-56(140)9-27(10-57(94)141)107(168)196-119)99(191-106(167)26-5-43(127)70(144)44(128)6-26)103-122(200-121)199-115(176)35-18-52(136)78(152)87(161)67(35)66-34(114(175)192-103)17-51(135)77(151)86(66)160/h1-21,60-61,95-103,119-164H,22-23H2/t60-,61-,95-,96-,97+,98+,99-,100-,101-,102-,103+,119+,120+,121-,122+/m1/s1
SMILES c1c(cc(c(c1O)O)O)C(=O)O[C@H]1[C@H]2[C@@H](COC(=O)c3cc(c(c(c3-c3c(cc(c(c3O)O)O)C(=O)O2)O)O)O)O[C@@H]2[C@@H]1OC(=O)c1cc(c(c(c1Oc1cc(cc(c1O)O)C(=O)O[C@H]1[C@@H]([C@H]([C@H]3[C@@H](COC(=O)c4cc(c(c(c4-c4c(cc(c(c4O)O)O)C(=O)O3)O)O)O)O1)OC(=O)c1cc(c(c(c1)O)O)O)OC(=O)c1cc(c(c(c1Oc1cc(cc(c1O)O)C(=O)O[C@H]1[C@@H]([C@H]([C@H]3[C@@H](OC(=O)c4cc(c(c(c4-c4c(cc(c(c4O)O)O)C(=O)O3)O)O)O)O1)OC(=O)c1cc(c(c(c1)O)O)O)OC(=O)c1cc(c(c(c1Oc1c(cc(cc1O)C(=O)O2)O)O)O)O)O)O)O)O)O)O

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   2794.24 Volume:   2457.875
?
Van der Waals volume.
Dense:   1.137 LogP:   -3.306
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   -6.105
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -5.805
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   9.0 Rigid Bonds:   170.0
TPSA:   1299.54
?
Topological Polar Surface Area.
H-Bond Acceptor:   78.0
H-Bond Donor:   42.0 Rings:   23.0
Heavy Atoms:   78.0

MedChem Properties

QED Drug-Likeness Score:   0.05 GASA:   1.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   9.511 Fsp3:   0.139
MCE-18:   535.36
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Accepted
Pfizer Rule:   Rejected GSK Rule:   Accepted
Golden Triangle Rule:   Accepted BMS Rule:   1
Chelating Alert:   1 PAINS Alert:   1
Colloidal aggregators:   1.0 Fluc inhibitor:   0.105
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.354
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.667
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.825 Promiscuous compounds:   0.873

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -11.552 MDCK Permeability:   -4.823
Pgp-inhibitor:   0.0 Pgp-substrate:   0.0
PAMPA:   1.0
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.0
20% Bioavailability (F20%):   0.546 30% Bioavailability (F30%):   0.868
50% Bioavailability (F50%):   1.0

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.0 MRP1:   1.0
Plasma Protein Binding (PPB):   70.168% Volume Distribution (VD):   0.104
Fu: 5.202%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   0.818
OATP1B3 inhibitor:   0.506 BCRP inhibitor:   0.0
BSEP inhibitor:   0.0

ADMET: Metabolism

CYP1A2-inhibitor:   0.0 CYP1A2-substrate:   0.0
CYP2C19-inhibitor:   0.0 CYP2C19-substrate:   0.0
CYP2C9-inhibitor:   0.0 CYP2C9-substrate:   0.0
CYP2D6-inhibitor:   0.0 CYP2D6-substrate:   0.0
CYP3A4-inhibitor:   0.0 CYP3A4-substrate:   0.0
CYP2B6-substrate:   0.0 CYP2C8-inhibitor:   1.0
HLM stability:   0.0
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  1.633 Half-life (T1/2):  16.422

ADMET: Toxicity

hERG Blockers:  0.0 hERG Blockers (10um):  1.0
Human Hepatotoxicity (H-HT):  0.441 Drug-induced Liver Injury (DILI):  1.0
AMES Toxicity:  1.0 Rat Oral Acute Toxicity:  0.003
Maximum Recommended Daily Dose:  0.997 Skin Sensitization:  1.0
Carcinogencity:  0.038 Eye Corrosion:  0.0
Eye Irritation:  0.003 Respiratory Toxicity:  0.0
Drug-induced Neurotoxicity:  0.0 Ototoxicity:  1.0
Hematotoxicity:  0.0 Drug-induced Nephrotoxicity:  0.193
Genotoxicity:  1.0 RPMI-8226 Immunitoxicity:  0.0
A549 Cytotoxicity:  1.0 Hek293 Cytotoxicity:  0.72
BCF:   -2.734
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   2.543
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   3.104
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   3.998
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO20417 Tamarix nilotica Species Tamaricaceae Eukaryota n.a. n.a. n.a. PMID[20405847]
NPO20417 Tamarix nilotica Species Tamaricaceae Eukaryota n.a. n.a. n.a. PMID[23675651]
NPO20417 Tamarix nilotica Species Tamaricaceae Eukaryota Leaves n.a. n.a. PMID[26938659]
NPO20786 Tamarix tetrandra Species Tamaricaceae Eukaryota Leaves n.a. n.a. PMID[26938659]
NPO20417 Tamarix nilotica Species Tamaricaceae Eukaryota n.a. n.a. n.a. Database[COCONUT]
NPO20786 Tamarix tetrandra Species Tamaricaceae Eukaryota n.a. n.a. n.a. Database[COCONUT]
NPO20417 Tamarix nilotica Species Tamaricaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO20417 Tamarix nilotica Species Tamaricaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO20786 Tamarix tetrandra Species Tamaricaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT116 Cell line HL-60 Homo sapiens CC50 = 30500.0 nM PMID[26938659]
NPT2394 Cell line HSC-4 Homo sapiens CC50 = 42900.0 nM PMID[26938659]
NPT2385 Cell line HSC-3 Homo sapiens CC50 = 34200.0 nM PMID[26938659]
NPT924 Cell line HSC-2 Homo sapiens CC50 = 22300.0 nM PMID[26938659]
NPT2 Others Unspecified n.a. CC50 > 100000.0 nM PMID[26938659]
NPT2 Others Unspecified n.a. CC50 = 90700.0 nM PMID[26938659]
NPT2 Others Unspecified n.a. CC50 = 96600.0 nM PMID[26938659]

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC488884 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9512 High Similarity NPC194439
0.9512 High Similarity NPC33724
0.9268 High Similarity NPC488885
0.8554 High Similarity NPC223534
0.8537 High Similarity NPC112211
0.8537 High Similarity NPC254925
0.8372 Intermediate Similarity NPC187632
0.8372 Intermediate Similarity NPC240200
0.8211 Intermediate Similarity NPC31208
0.8211 Intermediate Similarity NPC160543
0.8193 Intermediate Similarity NPC40078
0.7816 Intermediate Similarity NPC290289
0.7742 Intermediate Similarity NPC488887
0.7742 Intermediate Similarity NPC488886
0.7701 Intermediate Similarity NPC483712
0.7701 Intermediate Similarity NPC158214
0.7701 Intermediate Similarity NPC214202
0.75 Intermediate Similarity NPC97924
0.7423 Intermediate Similarity NPC469652
0.7423 Intermediate Similarity NPC486025
0.7423 Intermediate Similarity NPC486024
0.7273 Intermediate Similarity NPC93065
0.7273 Intermediate Similarity NPC220876
0.6832 Remote Similarity NPC260521
0.6762 Remote Similarity NPC174140
0.6735 Remote Similarity NPC471091
0.66 Remote Similarity NPC469649
0.6585 Remote Similarity NPC469651
0.6463 Remote Similarity NPC43918
0.6463 Remote Similarity NPC261411
0.6463 Remote Similarity NPC190204
0.6341 Remote Similarity NPC47521
0.604 Remote Similarity NPC116108
0.5354 Remote Similarity NPC269625
0.5181 Remote Similarity NPC114791
0.5181 Remote Similarity NPC104222
0.5181 Remote Similarity NPC210501
0.5181 Remote Similarity NPC318826
0.5181 Remote Similarity NPC141331
0.5109 Remote Similarity NPC149300

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC488884 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
NPD

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data